Condition (MeSH)
Diabetes Mellitus, Experimental
ClinicalTrials.gov lists 3 trials for Diabetes Mellitus, Experimental or a narrower condition beneath it. National Center for Research Resources (NCRR) has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Diabetes Mellitus, Experimental itself; the rest are tagged with a narrower condition beneath it.
When did Diabetes Mellitus, Experimental trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2019 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Diabetes Mellitus, Experimental trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 3 | 1 |
| Not applicable | 1 |
How many Diabetes Mellitus, Experimental trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Diabetes Mellitus, Experimental trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 1 |
Which publications cover Diabetes Mellitus, Experimental? (467)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Pathogenic dengue virus TW2015 strain infection triggers anaerobic glycolysis and enhances mortality in diabetic mice. | Journal of virology | 2025 | Yes |
| Phoenixin-14 protects cardiac damages in a streptozotocin-induced diabetes mice model through SIRT3. | Archives of physiology and biochemistry | 2024 | Yes |
| Metabolic Communication by SGLT2 Inhibition. | Circulation | 2024 | Yes |
| A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut. | Gut | 2023 | Yes |
| Skeletal Muscle Atrophy Induced by Diabetes Is Mediated by Non-Selective Channels and Prevented by Boldine. | Biomolecules | 2023 | Yes |
Showing 5 of 467 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.